Stay updated on Opregen in Geographic Atrophy Clinical Trial
Sign up to get notified when there's something new on the Opregen in Geographic Atrophy Clinical Trial page.

Latest updates to the Opregen in Geographic Atrophy Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedThe webpage has updated its date listings, adding several future dates while removing others. Notably, the previous notices regarding service performance and contact information have been removed.SummaryDifference4%
- Check32 days agoNo Change Detected
- Check39 days agoChange DetectedThe web page now includes a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference2%
- Check46 days agoChange DetectedThe website has been updated from version 2.14.1 to 2.14.2.SummaryDifference0.1%
- Check60 days agoChange DetectedThe website has been updated from version 2.14.0 to 2.14.1.SummaryDifference0.1%
- Check67 days agoChange DetectedThe study has expanded to 7 locations, including new sites in Blue Ash, Ohio, and Tel Aviv, Israel, while the previous version listed only 6 locations and had different details.SummaryDifference3%
- Check89 days agoChange DetectedThe website has updated its information on data sharing, replacing the previous access details with a new commitment to transparency for eligible studies, while also removing older updates and links.SummaryDifference4%
Stay in the know with updates to Opregen in Geographic Atrophy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Opregen in Geographic Atrophy Clinical Trial page.